KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.7000
-0.0200 (-2.78%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous Close0.7200
Open0.7200
Bid0.7000 x 0
Ask0.7100 x 0
Day's Range0.6900 - 0.7200
52 Week Range0.3000 - 2.6900
Volume282,949
Avg. Volume403,503
Market Cap81.271M
Beta (5Y Monthly)2.17
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results
    CNW Group

    Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results

    Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results

  • Khiron Begins Sales of First High-THC Medical Cannabis in Colombia
    CNW Group

    Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

    TORONTO , May 20, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe , announced today that it has received authorization from Colombia's National Narcotics Fund for the sale of magistral preparation of high-THC medical cannabis. With this authorization Khiron becomes the first and, to date, only company fully authorized to manufacture and sell high-THC medical cannabis for patient prescriptions in Colombia .

  • Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference
    CNW Group

    Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference

    TORONTO, May 7, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQX:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that President Chris Naprawa will present live at Canaccord Genuity's 4th Annual Global Cannabis Virtual Conference on Tuesday, May 12, 2020 at 11:40am ET (8:40am PT). Canaccord Genuity's Annual Global Cannabis Conference is an investor-focused virtual event that engages a global network of leading players in the cannabis industry.

  • Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21
    CNW Group

    Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

    Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

  • Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update
    CNW Group

    Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update

    Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update

  • Khiron Signs Exclusive Agreement with Medlive, a Distributor Serving 3,000 Clinics and Hospitals in Brazil
    CNW Group

    Khiron Signs Exclusive Agreement with Medlive, a Distributor Serving 3,000 Clinics and Hospitals in Brazil

    TORONTO , April 30, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe , announces that it has entered into an exclusive agreement with Medlive, a leading marketer and distributor of pharmaceutical products to clinics, hospitals and pharmacies in southern Brazil . Through this agreement physicians in Medlive's extensive network will receive medical education and training related to Khiron products.

  • Khiron Provides Update on Filing of its 2019 Year End Results
    CNW Group

    Khiron Provides Update on Filing of its 2019 Year End Results

    TORONTO , April 28, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , announces that it will delay the filing of its audited financial statements and accompanying management's discussion and analysis for the year ended December 31, 2019 and is relying on the filing extension provided by the Ontario Securities Commission on March 23, 2020 , in response to the COVID-19 pandemic. The relief measures are contained in Ontario Instrument 51-502 entitled "Temporary Exemption from Certain Corporate Finance Requirements" (the "Exemption"). While the Company prepared for and expected that its 2019 year-end financial results would be released by the April 29, 2020 filing deadline, it was informed by the Company's independent auditors, MNP LLP ("MNP"), that they are unable to complete the audit in time for the filing deadline due to delays caused by the COVID-19 situation.

  • Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel
    CNW Group

    Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel

    Khiron Signs Medical Cannabis Distribution Deal in Colombia With Locatel

  • Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update
    CNW Group

    Khiron to Report 2019 Fiscal Year End Results and Provides Corporate Update

    Khiron to report Q4 and Year End Results on April 28 , and webcast Q&A will be held the following day Khiron finished the 2019 calendar year with approximately $36 Million CAD in cash and working capital ...

  • Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University
    CNW Group

    Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University

    Khiron to Educate Physicians on Medical Cannabis Online with Leading Latin American University

  • Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia
    CNW Group

    Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia

    Khiron Meets Essential Patient Needs with Launch of Teleconsultation Services in Colombia

  • CNW Group

    IIROC Trading Resumption - KHRN

    IIROC Trading Resumption - KHRN

  • Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update
    CNW Group

    Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update

    Khiron Readies for First Medical Sales in Colombia and Provides Corporate Update

  • CNW Group

    IIROC Trading Halt - KHRN

    IIROC Trading Halt - KHRN

  • Khiron Poised to Enter Medical Cannabis Market in Peru
    CNW Group

    Khiron Poised to Enter Medical Cannabis Market in Peru

    Khiron Poised to Enter Medical Cannabis Market in Peru

  • ACCESSWIRE

    Khiron President Chris Naprawa To Present at 2020 LD Micro Virtual Conference

    TORONTO, ON / ACCESSWIRE / March 3, 2020 / Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today announced today that the Company will be presenting at the third annual LD Micro Virtual Conference on Tuesday March 3rd at 1:40pm PST/4:40pm EST. Khiron President Chris Naprawa will present and take questions from investors.

  • Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia
    CNW Group

    Khiron is First Company Authorized to Extract High THC Medical Cannabis in Colombia

    Further to cultivation quotas announced on February 26, 2020, this authorization by the Colombian Technical Quotas Authority ("TQG") allows the Company to now produce oils for sale both domestically and abroad. Export quotas allow for the manufacture of whole plant extract for international purposes to countries such as Peru, Uruguay and Brazil, thereby accessing to a medical cannabis market of $1.4 Billion. Domestic quotas represent a further milestone in the Company's stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy.

  • Khiron Receives Approval of Normal Course Issuer Bid
    CNW Group

    Khiron Receives Approval of Normal Course Issuer Bid

    TORONTO , Feb. 27, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), a vertically integrated cannabis leader with core operations in Latin America , is pleased to announce that, further to its February 11, 2020 press release, the Company has received final approval from the TSX Venture Exchange (the "TSXV") for a normal course issuer bid to repurchase, for cancellation, up to 5,830,615 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding Shares (the "NCIB").

  • Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17% of the Total Allocated Quota for Colombia in 2020
    CNW Group

    Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17% of the Total Allocated Quota for Colombia in 2020

    Colombia was granted a total production quota of 56.2 tons of medical cannabis for 2020 by the International Narcotics Control Board ("INCB"), the entity responsible for the implementation of the United Nations drug conventions. This represents 21.9% of the world´s legal global supply of high THC medical cannabis. The Company will begin cultivation activities immediately in its existing state-of-the-art facility near Ibague, Colombia , with its already-registered strains.

  • Khiron Announces Plans to Expand Kuida® Distribution to Spain
    CNW Group

    Khiron Announces Plans to Expand Kuida® Distribution to Spain

    Khiron Announces Plans to Expand Kuida® Distribution to Spain

  • Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC
    CNW Group

    Khiron to Participate in 3rd Annual Gravitas Growth Conference in Vancouver, BC

    TORONTO , Feb. 14, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , is pleased to announce it will be participating in the 3rd Annual Gravitas Growth Conference taking place February 20 th, 2020 at the Fairmont Pacific Rim Hotel in Vancouver , BC.

  • Khiron Announces Normal Course Issuer Bid
    CNW Group

    Khiron Announces Normal Course Issuer Bid

    TORONTO, Feb. 11, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces today its intention to commence a normal course issuer bid through the facilities of the TSX Venture Exchange (the "TSXV") to repurchase, for cancellation, up to 5,830,615 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstanding Shares (the "NCIB").

  • Khiron to Host Investor Webcast Live on February 11, 2020
    CNW Group

    Khiron to Host Investor Webcast Live on February 11, 2020

    TORONTO , Feb. 10, 2020 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , is pleased to announce that Chris Naprawa , President, will present live at Grit Capital's Webcast Series on February 11 th, 2020 at 11:00am ET / 8:00am PT .

  • Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product
    CNW Group

    Brazil Health Agency Authorizes Import of Khiron Medical Cannabis Product

    Authorization from the Brazilian Health Regulatory Agency (ANVISA) allows for Khiron medical cannabis product to be imported for use on an individual patient basis Authorization follows December 2019 announcement ...

  • Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic
    CNW Group

    Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic

    Khiron Increases Clinical Capacity in Colombia by 75% with Opening of Zerenia Integrated Medical Clinic